Foamy Virus Integrase in Development of Viral Vector for Gene Therapy

키워드

참고문헌 (128)

1. Busch H, "Genetic engineering and cancer chemotherapy", Oncology, 26, pp.152~179 (1972)
2. Goff SP, "Construction of hybrid viruses containing SV40 and l phage DNA segments and their propagation in cultured monkey cells", Cell, 9, pp.695~705 (1976)
3. Cepko CL, "Construction and applications of a highly transmissible murine retrovirus shuttle vector", Cell, 37, pp.1053~1062 (1984)
4. Rosenberg SA, "Gene transfer into humans—immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction", N. Engl. J. Med, 323, pp.570~578 (1990)
5. "Gene Therapy Clinical Trials Worldwide Database" (2019)[URL]
6. Baum C, "Side effects of retroviral gene transfer into hematopoietic stem cells", Blood, 101, pp.2099~2114 (2003)
7. Raper SE, "Fatal systemic inflammatory response syndrome in an ornithine transcarbamylase deficient patient following adenoviral gene transfer", Mol. Genet. Metab, 80, pp.148~158 (2003)
8. Hidai C, "Nonviral gene therapy for cancer : a review", Diseases, 6, pp.57~ (2018)
9. Enders JF, "Propagation in tissue cultures of cytopathogenic agents from patients with measles", Proc. Soc. Exp. Biol. Med, 86, pp.277~286 (1954)
10. Lindemann D, "Foamy virus biology and its application for vector development", Viruses, 3, pp.561~585 (2011)
11. Meiering CD, "Historical perspective of foamy virus epidemiology and infection", Clin. Microbiol. Rev, 14, pp.165~176 (2001)
12. Moebes A, "Human foamy virus reverse transcription that occurs late in the viral replication cycle", J. Virol, 71, pp.7305~7311 (1997)
13. Khan AS, "Spumaretroviruses : updated taxonomy and nomenclature", Virology, 516, pp.158~164 (2018)
14. King AMQ, "Changes to taxonomy and the international code of virus classification and nomenclature ratified by the International Committee on Taxonomy of Viruses(2018)", Arch. Virol, 163, pp.2601~2631 (2018)
15. Hamann MV, "Efficient transient genetic manipulation in vitro and in vivo by prototype foamy virus-mediated nonviral RNA transfer", Mol. Ther, 22, pp.1460~1471 (2014)
16. Burtner CR, "Intravenous injection of a foamy virus vector to correct canine SCID-X1", Blood, 123, pp.3578~3584 (2014)
17. Humbert O, "Rapid immune reconstitution of SCID-X1canines after G-CSF", AMD3100 mobilization and in vivo gene therapy, 2018, pp.2, 987~999
18. Rajawat YS, "In-vivo gene therapy with foamy virus vectors", Viruses, 11, pp.1091~ (2019)
19. Trobridge GD, "Large animal models for foamy virus vector gene therapy", Viruses, 4, pp.3572~3588 (2012)
20. Vassilopoulos G, "Gene transfer into murine hematopoietic stem cells with helper-free foamy virus vectors", Blood, 98, pp.604~609 (2001)
21. Meng J, "Restoration of functional full-length dystrophin after intramuscular transplantation of foamy virus-transduced myoblasts", Hum. Gene. Ther, 31, pp.241~252 (2020)
22. Engelman A, "Retroviral integrase structure and DNA recombination mechanism", Microbiol. Spectr, 2, pp.1~22 (2014)
23. Maskell DP, "Structural basis for retroviral integration into nucleosomes", Nature, 523, pp.366~369 (2015)
24. Valkov E, "Functional and structural characterization of the integrase from the prototype foamy virus", Nucleic Acids Res, 37, pp.243~255 (2009)
25. Lopez Jr MA, "Detection and removal of nuclease contamination during purification of recombinant prototype foamy virus integrase", J. Vis. Exp, 130, pp.e56605~ (2017)
26. Engelman AN, "Retroviral intasomes arising", Curr. Opin. Struct. Biol, 47, pp.23~29 (2017)
27. Ciuffi A, "Retroviral DNA integration : HIV and the role of LEDGF", p75, 2006, pp.22, 388~395
28. Delelis O, "Insight into the integrase-DNA recognition mechanism : a specific DNA-binding mode revealed by an enzymatically labeled integrase", J. Biol. Chem, 283, pp.27838~27849 (2008)
29. Chow SA, "Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus", Science, 255, pp.723~726 (1992)
30. Kulkosky J, "Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral", retrotransposon integrases and bacterial insertion sequence transposases, 1992, pp.12, 2331~2338
31. Drelich M, "Identification of amino acid residues critical for endonuclease and integration activities of HIV-1 IN protein in vitro", Virology, 188, pp.459~468 (1992)
32. Li M, "Outer domains of integrase within retroviral intasomes are dispensible for catalysis of DNA integration", Protein Sci, 25, pp.472~478 (2016)
33. Engelman A, "HIV-1 DNA integration : mechanism of viral DNA cleavage and DNA strand transfer", Cell, 67, pp.1211~1221 (1991)
34. Davies DR, "Three-dimensional structure of the Tn5 synaptic complex transposition intermediate", Science, 289, pp.77~85 (2000)
35. Nowotny M, "Retroviral integrase superfamily : the structural perspective", EMBO Rep, 10, pp.144~151 (2009)
36. Enssle J, "An active foamy virus integrase is required for virus replication", J. Gen. Virol, 80, pp.1445~1452 (1999)
37. Dyda F, "Crystal structure of the catalytic domain of HIV-1integrase : similarity to other polynucleotidyl transferases", Science, 266, pp.1981~1986 (1994)
38. Yang W, "Making and breaking nucleic acids : two-Mg2+-ion catalysis and substrate specificity", Mol. Cell, 22, pp.5~13 (2006)
39. Cherepanov P, "Activity of recombinant HIV-1 integrase on mini-HIV DNA", Nucleic Acids Res, 27, pp.2202~2210 (1999)
40. Villanueva RA, "Differential multimerization of Moloney murine leukemia virus integrase purified under nondenaturing conditions", Virology, 316, pp.146~160 (2003)
41. Lopez Jr MA, "Removal of nuclease contamination during purification of recombinant prototype foamy virus integrase", J. Virol. Methods, 235, pp.134~138 (2016)
42. 우귀웅, "Biochemical characteristics of functional domains using feline foamy virus integrase mutants", BMB Reports, 46(1), pp.53~58 (2013), 생화학분자생물학회
43. Lee GE, "Single residue mutation in integrase catalytic core domain affects feline foamy viral DNA integration", Biosci. Biotechnol. Biochem, 83, pp.270~280 (2019)
44. 이동현, "Characterization of Biochemical Properties of Feline Foamy Virus Integrase", Journal of Microbiology and Biotechnology, 20(6), pp.968~973 (2010), 한국미생물·생명공학회
45. Ballandras-Colas A, "Biochemical characterization of novel retroviral integrase proteins", PLoS One, 8, pp.e76638~ (2013)
46. Bera S, "Molecular interactions between HIV-1 integrase and the two viral DNA ends within the synaptic complex that mediates concerted integration", J. Mol. Biol, 389, pp.183~198 (2009)
47. Li M, "Retroviral DNA integration : reaction pathway and critical intermediates", EMBO J, 25, pp.1295~1304 (2006)
48. Guiot E, "Relationship between the oligomeric status of HIV-1 integrase on DNA and enzymatic activity", J. Biol. Chem, 281, pp.22707~22719 (2006)
49. Faure A, "HIV-1 integrase crosslinked oligomers are active in vitro", Nucleic Acids Res, 33, pp.977~986 (2005)
50. Bao KK, "Functional oligomeric state of avian sarcoma virus integrase", J. Biol. Chem, 278, pp.1323~1327 (2003)
51. Jonsson CB, "Functional domains of Moloney murine leukemia virus integrase defined by mutation and complementation analysis", J. Virol, 70, pp.4585~4597 (1996)
52. van Gent DC, "Complementation between HIV integrase proteins mutated in different domains", EMBO J, 12, pp.3261~3267 (1993)
53. Engelman A, "Identification of discrete functional domains of HIV‐1 integrase and their organization within an active multimeric complex", EMBO J, 12, pp.3269~3275 (1993)
54. Jones KS, "Retroviral integrase functions as a multimer and can turn over catalytically", J. Biol. Chem, 267, pp.16037~16040 (1992)
55. Wei SQ, "A large nucleoprotein assembly at the ends of the viral DNA mediates retroviral DNA integration", EMBO J, 16, pp.7511~7520 (1997)
56. Chen H, "Multiple integrase functions are required to form the native structure of the human immunodeficiency virus type I intasome", J. Biol. Chem, 274, pp.17358~17364 (1999)
57. Grawenhoff J, "Retroviral integrase protein and intasome nucleoprotein complex structures", World J. Biol. Chem, 8, pp.32~44 (2017)
58. Maertens GN, "The mechanism of retroviral integration from X-ray structures of its key intermediates", Nature, 468, pp.326~329 (2010)
59. Hare S, "Retroviral intasome assembly and inhibition of DNA strand transfer", Nature, 464, pp.232~236 (2010)
60. Ballandras-Colas A, "A supramolecular assembly mediates lentiviral DNA integration", Science, 355, pp.93~95 (2017)
61. Roberts VA, "C-terminal domain of integrase binds between the two active sites", J. Chem. Theory Comput, 11, pp.4500~4511 (2015)
62. Serrao E, "Key determinants of target DNA recognition by retroviral intasomes", Retrovirology, 12, pp.39~ (2015)
63. Bosserman MA, "Loop202–208 in avian sarcoma virus integrase mediates tetramer assembly and processing activity", Biochemistry, 46, pp.11231~11239 (2007)
64. Hare S, "Structural basis for functional tetramerization of lentiviral integrase", PLoS Pathog, 5, pp.e1000515~ (2009)
65. Heuer TS, "Photo-cross-linking studies suggest a model for the architecture of an active human immunodeficiency virus type 1 integrase−DNA complex", Biochemistry, 37, pp.6667~6678 (1998)
66. Cherepanov P, "HIV-1 integrase forms stable tetramers and associates with LEDGF", p75 protein in human cells, 2003, pp.278, 372~381
67. Hare S, "3’-Processing and strand transfer catalysed by retroviral integrase in crystallo", EMBO J, 31, pp.3020~3028 (2012)
68. Yin Z, "Assembly of prototype foamy virus strand transfer complexes on product DNA bypassing catalysis of integration", Protein Sci, 21, pp.1849~1857 (2012)
69. Mackler RM, "Assembly and purification of prototype foamy virus intasomes", J. Vis. Exp, 133, pp.e57453~ (2018)
70. Bushman F, "Genome-wide analysis of retroviral DNA integration", Nat. Rev. Microbiol, 3, pp.848~858 (2005)
71. Wu X, "Weak palindromic consensus sequences are a common feature found at the integration target sites of many retroviruses", J. Virol, 79, pp.5211~5214 (2005)
72. Shun MC, "LEDGF", p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration, 2007, pp.21, 1767~1778
73. Holman AG, "Symmetrical base preferences surrounding HIV-1, avian sarcoma", leukosis virus, and murine leukemia virus integration sites, 2005, pp.102, 6103~6107
74. Schröder AR, "HIV-1 integration in the human genome favors active genes and local hotspots", Cell, 110, pp.521~529 (2002)
75. Crise B, "Simian immunodeficiency virus integration preference is similar to that of human immunodeficiency virus type 1", J. Virol, 79, pp.12199~12204 (2005)
76. MacNeil A, "Genomic sites of human immunodeficiency virus type 2(HIV-2)integration : similarities to HIV-1 in vitro and possible differences in vivo", J. Virol, 80, pp.7316~7321 (2006)
77. Hacker CV, "The integration profile of EIAV-based vectors", Mol. Ther, 14, pp.536~545 (2006)
78. Kang Y, "Integration site choice of a feline immunodeficiency virus vector", J. Virol, 80, pp.8820~8823 (2006)
79. Mitchell RS, "Retroviral DNA integration : ASLV, HIV, and MLV show distinct target site preferences", PLoS Biol, 2, pp.e234~ (2004)
80. Nowrouzi A, "Genome-wide mapping of foamy virus vector integrations into a human cell line", J. Gen. Virol, 87, pp.1339~1347 (2006)
81. Trobridge GD, "Foamy virus vector integration sites in normal human cells", Proc. Natl. Acad. Sci. USA, 103, pp.1498~1503 (2006)
82. Stevens SW, "Sequence analysis of the human DNA flanking sites of human immunodeficiency virus type 1integration", J. Virol, 70, pp.6459~6462 (1996)
83. Derse D, "Human T-cell leukemia virus type 1 integration target sites in the human genome : comparison with those of other retroviruses", J. Virol, 81, pp.6731~6741 (2007)
84. Berry C, "Selection of target sites for mobile DNA integration in the human genome", PLoS Comput. Biol, 2, pp.e157~ (2006)
85. 신차균, "Characterization of the Functional Domains of Human Foamy Virus Integrase Using Chimeric Integrases", Molecules and Cells, 19(2), pp.246~255 (2005), 한국분자세포생물학회
86. Kim J, "Integrase C-terminal residues determine the efficiency of feline foamy viral DNA integration", Virology, 514, pp.50~56 (2018)
87. Pahl A, "Characterization of the human spuma retrovirus integrase by site-directed mutagenesis, by complementation analysis, and by swapping the zinc finger domain of HIV-1", J. Biol. Chem, 270, pp.2957~2966 (1995)
88. Heinkelein M, "Pregenomic RNA is required for efficient incorporation of Pol polyprotein into foamy virus capsids", J. Virol, 76, pp.10069~10073 (2002)
89. Tobaly‐Tapiero J, "Chromatin tethering of incoming foamy virus by the structural Gag protein", Traffic, 9, pp.1717~1727 (2008)
90. Lo YT, "The foamy virus genome remains unintegrated in the nuclei of G1", S phase-arrested cells, and integrase is critical for preintegration complex transport into the nucleus, 2010, pp.84, 2832~2842
91. Müllers E, "Prototype foamy virus(PFV)Gag nuclear localization : a novel pathway among retroviruses", J. Virol, 85, pp.9276~9285 (2011)
92. An DG, "Characterization of nuclear localization signals of the prototype foamy virus integrase", J. Gen. Virol, 89, pp.1680~1684 (2008)
93. Md. Alamgir Hossain, "Nuclear Localization Signals in Prototype Foamy Viral Integrase for Successive Infection and Replication in Dividing Cells", Molecules and Cells, 37(2), pp.140~148 (2014), 한국분자세포생물학회[DOI]
94. Faysal Bin Hamid, "Characterization of Prototype Foamy Virus Infectivity in Transportin 3 Knockdown Human 293t Cell Line", Journal of Microbiology and Biotechnology, 27(2), pp.380~387 (2017), 한국미생물·생명공학회[DOI]
95. Ali MK, "Knockdown of the host cellular protein transportin 3 attenuates prototype foamy virus infection", Biosci. Biotechnol. Biochem, 79, pp.943~951 (2015)
96. Bodem J, "Regulation of foamy viral transcription and RNA export", Adv. Virus Res, 81, pp.1~31 (2011)
97. Yu SF, "Human foamy virus replication : a pathway distinct from that of retroviruses and hepadnaviruses", Science, 271, pp.1579~1582 (1996)
98. Bodem J, "Characterization of the spliced pol transcript of feline foamy virus : the splice acceptor site of the pol transcript is located in gag of foamy viruses", J. Virol, 70, pp.9024~9027 (1996)
99. Löchelt M, "Human foamy virus genome possesses an internal, Bel-1-dependent and functional promoter", Proc. Natl. Acad. Sci. USA, 90, pp.7317~7321 (1993)
100. Löchelt M, "The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein", Proc. Natl. Acad. Sci. USA, 102, pp.7982~7987 (2005)
101. Löchelt M, "Foamy Viruses", pp.27~61 (2003), Springer
102. Peters K, "Complex effects of foamy virus central purine-rich regions on viral replication", Virology, 373, pp.51~60 (2008)
103. Hartl MJ, "Regulation of foamy virus protease activity by viral RNA : a novel and unique mechanism among retroviruses", J. Virol, 85, pp.4462~4469 (2011)
104. Moschall R, "A purine-rich element in foamy virus pol regulates env splicing and gag", pol expression, 2017, pp.14, 10~
105. Lee EG, "Foamy retrovirus integrase contains a Pol dimerization domain required for protease activation", J. Virol, 85, pp.1655~1661 (2011)
106. Spannaus R, "The prototype foamy virus protease is active independently of the integrase domain", Retrovirology, 9, pp.41~ (2012)
107. Pahl A, "Endonucleolytic cleavages and DNA-joining activities of the integration protein of human foamy virus", J. Virol, 67, pp.5426~5434 (1993)
108. Sinha S, "Recombinant human immunodeficiency virus type 1 integrase exhibits a capacity for full-site integration in vitro that is comparable to that of purified preintegration complexes from virus-infected cells", J. Virol, 79, pp.8208~8216 (2005)
109. Li M, "Processing of viral DNA ends channels the HIV-1 integration reaction to concerted integration", J. Biol. Chem, 280, pp.29334~29339 (2005)
110. Knyazhanskaya ES, "Relative comparison of catalytic characteristics of human foamy virus and HIV-1 integrases", Acta Naturae, 1, pp.78~80 (2009)
111. Smolov M, "Kinetic study of the HIV-1 DNA 3‐end processing", FEBS J, 273, pp.1137~1151 (2006)
112. Kang, Seung Yi, "Functional Nucleotides of U5 LTR Determining Substrate Specificity ofPrototype Foamy Virus Integrase", Journal of Microbiology and Biotechnology, 18(6), pp.1044~1049 (2008), 한국미생물·생명공학회
113. Oh YT, "Comparison of enzymatic activities of the HIV‐1 and HFV integrases to their U5 LTR substrates", IUBMB Life, 47, pp.621~629 (1999)
114. Aiyer S, "Structural and sequencing analysis of local target DNA recognition by MLV integrase", Nucleic Acids Res, 43, pp.5647~5663 (2015)
115. Mackler RM, "Prototype foamy virus integrase is promiscuous for target choice", Biochem. Biophys. Res. Commun, 503, pp.1241~1246 (2018)
116. Cavazza A, "Mechanisms of retroviral integration and mutagenesis", Hum. Gene Ther, 24, pp.119~131 (2013)
117. Trobridge G, "Improved foamy virus vectors with minimal viral sequences", Mol. Ther, 6, pp.321~328 (2002)
118. Heinkelein M, "Improved primate foamy virus vectors and packaging constructs", J. Virol, 76, pp.3774~3783 (2002)
119. Wiktorowicz T, "Generation of an improved foamy virus vector by dissection of cis-acting sequences", J. Gen. Virol, 90, pp.481~487 (2009)
120. Müllers E, "Novel functions of prototype foamy virus Gag glycinearginine-rich boxes in reverse transcription and particle morphogenesis", J. Virol, 85, pp.1452~1463 (2011)
121. Bauer Jr TR, "Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors", Nat. Med, 14, pp.93~97 (2008)
122. Bauer Jr TR, "Long-term follow-up of foamy viral vector-mediated gene therapy for canine leukocyte adhesion deficiency", Mol. Ther, 21, pp.964~972 (2013)
123. Hocum JD, "Retargeted foamy virus vectors integrate less frequently near proto-oncogenes", Sci. Rep, 6, pp.36610~ (2016)
124. Deyle DR, "Nonintegrating foamy virus vectors", J. Virol, 84, pp.9341~9349 (2010)
125. Nasimuzzaman M, "Production and purification of high-titer foamy virus vector for the treatment of leukocyte adhesion deficiency", Mol. Ther. Methods Clin. Dev, 3, pp.16004~ (2016)
126. Merten OW, "Production of lentiviral vectors", Mol. Ther. Methods Clin. Dev, 3, pp.16017~ (2016)
127. Sweeney NP, "Delivery of large transgene cassettes by foamy virus vector", Sci. Rep, 7, pp.8085~ (2017)
128. Sweeney NP, "Rapid and efficient stable gene transfer to mesenchymal stromal cells using a modified foamy virus vector", Mol. Ther, 24, pp.1227~1236 (2016)

관련 논문AI추천